Andrew Holtz, author of House, MD, spent 17 years at CNN, during 10 of which he covered medicine. He holds a masters degree in public health from Portland State University and writes a regular column for Oncology Times. On page 48, he reports on scientists who are trying to use viruses to treat cancer. ?The story is an interesting intersection of business and science,? say Holtz. ?Companies and academics are now trying to show that oncovirus can compete with conventional treatments, and make that statement emphatically enough to get some investment.?
Survey Series
For Advertisers
(continued >>)
To continue reading this full article, you must be a subscriber to The Scientist.
You are only a few minutes away from unlimited access.
If you already have an online subscription, please Log-In Now.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
Subscribe to The Scientist to get unlimited access to our premium content
Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95. Subscribe now.The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.